HIV-treatment. Interactions, compliance, prolonged adverse effects and global accessibility
Gerstoft, J.
Ugeskrift for Laeger 162(35): 4639
2000
ISSN/ISBN: 0041-5782 PMID: 10986887 Document Number: 525766
Document emailed within 1 workday
Related Documents
Payk, T.R. 1979: Adverse effects and interactions in therapy with psychopharmaceuticals Medizinische Monatsschrift für Pharmazeuten 2(11): 336-340Kaye, S.; Ortiz, T.; Miranda Massari, J.R.; González, M.J. 2003: Adverse effects and interactions of medicinal herbal products Boletin de la Asociacion Medica de Puerto Rico 95(6): 32-36; 40-41
Wynn, R.L. 1994: Dental drug interactions with the greatest potential for serious adverse effects General Dentistry 42(2): 116-117
Robinson, D.S. 1984: Adverse reactions, toxicities, and drug interactions of newer antidepressants: anticholinergic, sedative, and other side effects Psychopharmacology Bulletin 20(2): 280-290
Crane, J. 2010: Adverse events and placebo effects: African scientists, HIV, and ethics in the 'global health sciences' Social Studies of Science 40(6): 843-870
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Sepúlveda, B. 1970: Adverse effects of contraceptives. II. Adverse effects of contraceptive steroids on the liver Gaceta Medica de Mexico 100(8): 823-831
Nilsson, P. 2000: Impossible to document adverse effects of calcium antagonists. Effects equal to those of conservative treatment of hypertension Lakartidningen 97(35): 3710-3712
Mant, A. 1999: Compliance and the adverse event profile Australian Family Physician 28(6): 591
2011: Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice Prescrire International 20(116): 128-133
Wiskemann, A. 1979: Adverse effects in the treatment of psoriasis Zfa. Zeitschrift für Allgemeinmedizin 55(29): 1657
Sharma, A.; Vora, R.; Modi, M.; Sharma, A.; Marfatia, Y. 2008: Adverse effects of antiretroviral treatment Indian Journal of Dermatology Venereology and Leprology 74(3): 234-237
Kuriyama, T.; Kawamata, T. 2016: Adverse Effects of Antidepressants and their Treatment Masui. Japanese Journal of Anesthesiology 65(7): 718-723
Petzoldt, D. 1973: Vitiligo: new possibilities in the treatment and its adverse effects Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 24(5): 221-222
Garrone, G.; Balant, L.; Balant-Gorgia, A. 1987: Problems encountered in the pharmacological treatment of depression (resistance to treatment, metabolic problems, undesirable secondary effects, non-compliance) Revue Medicale de la Suisse Romande 107(12): 1007-1012
Graves, D.; Cocohoba, J.; Gruta, C.; Goldschmidt, R. 2004: Potential adverse effects and inferior efficacy in ARV treatment Journal of the National Medical Association 96(5): 692